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Abstract
Background: Trypanosoma cruzi multiplies and differentiates in the digestive tract of triatomine insects. Xenodiagnosis
(XD) is a parasitological tool in which the insect vectors acts as a biological culture medium to amplify and detect T.
cruzi infection in mammals. The sensitivity of XD has been overcome by the application of PCR in fecal samples (FS) of
XD (PCR-XD). In this study, T. cruzi amplified in Triatoma infestans fed by XD on individuals with chronic Chagas disease
(CChD) is quantified by real-time PCR (qPCR-XD).
Findings: Under informed consent, 100 individuals were evaluated. In 21 of them XD, PCR-XD and qPCR-XD were
positive. For the contrary, 79 were negative XD. In 58 (73.4 %) and 66 cases (83.5 %) of them, PCR-XD (Fisher’s exact test
P = 0.005) and qPCR-XD (Fisher’s exact test: P = 0.037) respectively, were positive. In cases with positive XD, qPCR-XD
allowed to establish that in 9/21 cases (42.9 %) the parasite burden fluctuated between 100 and 1,000 par. eq./ml.
Otherwise, in 32/79 (40.5 %) cases with negative XD, a parasite burden between 1 and 10 par. eq./ml was determined.
All samples showed amplification of exogenous internal control (X12, Ct average: 31.8), so problems in the DNA
extraction (excess or loss of genetic material), unspecific amplification and/or inhibition in qPCR-XD reactions were
ruled out. Additionally, in all the patients qPCR in blood (qPCR-B) was performed. In the cases with positive XD, the
concordance between the positivity of qPCR-XD and qPCR-B was 100 %, nevertheless, the parasite burden in blood
was lower and different than XD (Chi-square test: χ2 = 91.82, df = 5, P = 0.0001). In the cases with negative XD the
ranges of qPCR-XD and qPCR-B were similar (Chi-square test: χ2 = 6.71, df = 5, P = 0.1520).
Conclusions: This study allowed the detection and quantification of T. cruzi by qPCR-XD in FS of Tr. infestans fed
on patients with CChD. The highest parasite burden was observed in positive XD cases. qPCR-XD could be used
in different studies related with the complex T. cruzi-vector-host interactions.
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Background
Chagas disease (ChD) is a zoonosis caused by the parasite
Trypanosoma cruzi endemic to the Americas, where it is
vector-borne by triatomine bugs (subfamily Triatominae).
An estimated 5.7 million people are infected with ChD in
21 Latin American countries [42]. In 1999, Chile was
declared free of transmission of T. cruzi by Triatoma
infestans; however, it is estimated that 140,000 people are
infected with T. cruzi in the country, mostly without tripa-
nocidal treatment [36, 37, 50]. Human ChD has two clin-
ical phases. The acute phase appears just after infection
while the chronic phase may last several years. After a
long asymptomatic phase, around 30 % of infected indi-
viduals develop chronic disease with severe damage to the
heart and digestive system [45]. In control treatment of an
individual with ChD (pre and post-therapy), it is essential
to determine the parasitological condition [38]. The clas-
sical xenodiagnosis (XD) [8, 32] has been used as a tool of
selection for specific treatment and its posterior evalu-
ation [2, 7, 16], searching for the most effective triatomine
species [9], isolation and characterization of T. cruzi DTUs
[13, 26, 33, 34, 47], comparison of its sensitivity with other
procedures for the detection of T. cruzi in bloodstream
[6, 51] and relation parasite cycle-vector [18, 41]. In
most of these studies, the result of XD has been expressed
in qualitative terms, i.e. fundamentally based on the micro-
scopic observation of mobile tripomastigote forms of T.
cruzi [11, 23, 39]. The high copy numbers of repetitive se-
quences contained in nuclear and kinetoplast DNA of T.
cruzi [16, 17] has allowed the successful application of PCR
to detect the parasite. The XD has less sensitivity than PCR
but the combination with PCR (qualitative PCR-XD) in dif-
ferent biological samples and hosts, improves its sensitivity
[15, 19–22, 28, 29, 35, 47, 51]. The objective of this study is
to detect and quantify T. cruzi in Tr. infestans fed by XD
on individuals with CChD by real-time PCR (qPCR-XD).
Methods
Study population
A total of 100 individuals with CChD, 31 men and 69
women (average age 49.6 years; range 10–79) were
identified during a serological survey performed be-
tween 2012 and 2014. All participants were from rural
and urban localities of the Provinces of Limarí and
Choapa IV Region, Coquimbo, located between 29°
02’S and 32°16’S in an area of transverse valleys of
Chile. With a population of 718,717 inhabitants,
21.9 % come from rural settings [30]. T. cruzi infection
was determined previously by Chagatek ELISA (Biomerieux
Corp., Buenos Aires, Argentina) and IFI-IgG (in house
developed). Previous clinical evaluations found that all of
the cases were asymptomatic at baseline and had not
received tripanocidal drugs.
Xenodiagnosis
Xenodiagnosis was carried out using two cages, each
containing seven uninfected III or IV instar nymphs of
Tr. infestans. The method, criteria of positivity and the
preparation of fresh fecal samples (FS) for PCR-XD are
described in Saavedra et al. [46]. Before FS-DNA isola-
tion an exogenous internal control (EIC) was added [4].
DNA purification was performed as described [2].
PCR-xenodiagnosis (PCR-XD)
PCR-XD was performed in triplicate using oligonucleotides
121 and 122, which anneal to the four conserved regions
present in T. cruzi minicircles (kDNA-T. cruzi) [17]. Each
sample was tested in a final volume of 20 μl including 5 μl
of extracted DNA. The final concentrations of reagents,
amplification program, control PCR and electrophoresis
were performed as described [46]. A positive result for
PCR-XD was the presence of a 330 bp specific band for
DNAT. cruzi.
Real-time PCR-xenodiagnosis (qPCR-XD)
To obtain a standard curve to perform the quantification
of T. cruzi, we used a stock of epimastigote forms of
Tulahuén (Tc VI) and Dm28c (Tc I) strains, starting with
a known concentration of parasite DNA and performing
serial dilutions (1:10) in DNA extracted of FS of negative
XD applied under Informed Consent of volunteer without
ChD, defining seven points ranging from 105 to 10-1 para-
site equivalent/ml (par. eq./ml). All calculations were
made assuming that T. cruzi genetic material has a mass
of 200 fg [19]. The standard curve of T. cruzi was accepted
considering the average of the tests with an efficiency (Eff)
of 99.0 %, linearity (Y) of -3.346 and correlation (R2) of
0.999 and on the other hand of human chromosome 12
(X12) with an Eff of 102.4 %, Y of -3.226 and R2 of 0.997.
The standard curve of CIE corresponding to X12 was
designed to discard false-negative cases caused by the ab-
sence of DNA in the evaluated sample due to extraction
problems, and to assess whether there was inhibition in
the PCR reaction. The primers N1X12 forward (5′-AGC
TGG CTA GAC TGT CAT-3′) and N2X12 reverse (5′
CTT TGC CGT TGA AGC TTG-3′) and the probe
N3X12 (5'-TGG GAC TTC AGA GTA GGC AGA TCG-
3') were used as described [2, 4]. The standard curve for
X12 was prepared with a pool of human genomic DNA of
5 individuals with ELISA and IFI-IgG negative for T. cruzi.
After extraction and purification, total DNA quantification
was carried out using AccuBlue™ High Sensitivity dsDNA
Quantitation Kit (Biotium Inc., California, USA) in a
qPCR instrument Mx3000P (Stratagene, Agilent Technolo-
gies Inc., California, USA) as detector devices. The average
concentration of total genomic DNA was 3.4 ng/μl. Later,
six points of dilution 1:5 in elution buffer Qiagen kit were
performed. The concentrations ranged between 3.40 and
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0.00108 ng/μl. The standard curve of X12 was maintained
at -20 °C until use. The reaction mixture was composed of
2 μl of the sample to be investigated in duplicate, 10 μl of
Brilliant Multiplex QPCR Master Mix, 0.5 μl of a 1:500
dilution of a reference dye (ROX), 2 μl of primers N1X12
and N2X12, 0.8 μl of probe N3X12, 0.2 μl of BSA (100×)
(BioLabs Inc., New England, UK) and 2.5 μl of molecular
biology grade water, in a final reaction volume of 20 μl.
qPCR was applied in the pools of FS obtained by XD
to determine the presence and amount of T. cruzi amplified
by Tr. infestans using TaqMan™ detection system in a
thermocycler Stratagene Mx3000P (Stratagene, Agilent
Technologies, Inc., California, USA) as described [2]. The
following controls in duplicate were included in each reac-
tion: water, buffer, pool of FS-DNA extracted of 5 unin-
fected triatomines as negative control of T. cruzi and as
positive control a pool of FS-DNA of 5 XD of CChD indi-
viduals with parasitemia previously confirmed by positive
PCR and XD.
The controls of X12 in duplicate were water, buffer, pool
of DNA extracted (previously added to human DNA) of 5
individuals as a positive control and pool DNA of sample
XD of 5 individuals as a negative control.
The thermal profile of all qPCR assays consisted in
10 min of pre-incubation at 95 °C and 40 cycles of amp-
lification with one estimate time of reaction of 90 min.
The emitted fluorescence was registered at 60 °C at the
end of each cycle using the MxPro QPCR Software version
4.10 (Stratagene, Agilent Technologies Inc., California,
USA) for Mx3000P System that established the threshold
fluorescence value for each assay according to the settings
provided in Analysis Term Settings. The fluorescence under
threshold was considered negative (No Ct).
Statistical analyses
The data were analyzed using the Statistical Package for
the Social Sciences (SPSS version19.0 Chicago, Illinois,
USA) software. The description of the data was performed
by tables, percentages, and arithmetic mean. Fisher’s exact
test and Chi-square were applied for comparison of quali-
tative variables. In the quantitative variables, Levene's test
was applied to evaluate heteroscedasticity and Kruskal-
Wallis test for comparison between the averages of
parasite burden. In all statistical tests it was considered
statistically significant P < 0.05.
Results and discussion
XD is a procedure in which the insect vector is used as a
biological culture medium for the detection of T. cruzi
infection [21]. Of the 100 cases evaluated in this study
by XD, in 21 it was possible to observe microscopically
mobile forms of T. cruzi in the FS of triatomines. For
the contrary, in 79 cases, the XD was negative. To im-
prove the limited sensitivity of the direct observation,
especially in FS with low parasite numbers, molecular
diagnostic techniques such as PCR have been directly
applied in DNA extracted from FS [5, 18, 20, 40, 47]. In
humans and diverse mammal reservoirs, the utility of
PCR to detect T. cruzi in FS of triatomines fed by XD
has been reported [9, 10, 44, 46, 51]. For this reason, the
biological samples of this study (DNA extracted of FS
used in XD), represent a great advantage in relation to
T. cruzi DNA extracted from peripheral blood, because
even with very low parasitemia, the XD is capable of
amplification with an inoculum of at least a living para-
site [46], constituting irrefutable evidence of viable T.
cruzi. In the present study, 100 % of the cases with posi-
tive XD and 73.4 % with negative XD, were PCR-XD
(Fisher’s exact test: P = 0.005) positive (Fig. 1).
Nevertheless, PCR is a qualitative technique that is not
useful to quantify T. cruzi in peripheral blood or FS of
triatomines naturally infected or fed by XD on diverse
hosts. In this work, T. cruzi levels, by qPCR-XD in FS of
triatomines fed by XD in untreated individuals with
CChD were quantified by qPCR-XD with the aim of
assessing the ability of infection and multiplication of T.
cruzi in Tr. infestans incubated during 90 days post-feeding.
Additionally, qPCR in peripheral blood (qPCR-B) was per-
formed for all patients in the study as described [2].
The positivity of qPCR-XD in the XD negative group
was 83.5 % (Fisher’s exact test: P = 0.037). In Table 1, it
is possible to observe that T. cruzi quantification by
qPCR in the FS of positive cases by XD allowed us to es-
tablish that in 42.9 % (9/21 cases) the parasite burden
fluctuated between 100 and 1,000 par. eq./ml. In this
group, the smallest and largest parasite burden was be-
tween 1–10 par. eq./ml (9.5 %) and 1,000–10,000 par.
eq./ml (23.8 %). In cases with negative XD, 40.5 % of
them (32/79 cases), a parasite burden between 1–10 par.
eq./ml was detected. The lowest and highest parasite
burden fluctuated between 0.1–1 par. eq./ml (34.2 %)
and 100–1,000 par. eq./ml (2.5 %). The average of para-
site burden through qPCR-XD in the negative XD group
were lower than those of positive XD group: 15 and 752
par. eq./ml, respectively (Kruskal-Wallis test: χ2 = 43.248,
df = 1, P = 0.0001).
In relation to qPCR-B, in 21 cases with positive XD,
38.1 % (8 cases) and 33.3 % (7 cases) had parasite burden
between 0.1–1 and 1–10 par. eq./ml, respectively. Only
2 cases (9.6 %) had parasite burden greater than 100 par.
eq./ml. On the other hand, in the cases with negative
XD, 30 cases (38 %) had a parasite burden between 1–10
par. eq./ml, 29 cases (36.7 %) had a parasite burden
between 0.1–1 par. eq./ml, a single case had parasite
burden between 100–1,000 par. eq./ml. In 17 cases (21.5 %)
T. cruzi was not detected (Table 1). In the positive XD
group, the concordance between the positivity of qPCR-XD
and qPCR-B was 100 %; however the parasitemia ranges
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were different (Chi-square test: χ2 = 91.82, df = 5, P =
0.0001). In the negative XD group, qPCR-XD detected
four cases more than qPCR-B, but the statistical analysis
demonstrated that the ranges of parasitemia of qPCR-XD
and qPCR-B were similar (Chi-square test: χ2 = 6.71, df =5,
P = 0.1520) (Additional File 1: Table S1).
All samples evidenced amplification of X12 (Ct aver-
age: 31.8) so problems in the extraction process (excess
or loss of genetic material), unspecific reactions and/or
inhibition of qPCR-XD were discarded. The positive
control showed amplification of X12.
Are demonstrated that XD is a useful tool to detect
living T. cruzi in persons with CChD [46], therefore the
positivity of PCR-XD and qPCR-XD suggests the presence
of viable tripomastigotes naturally amplified by the bio-
logical vector. Nevertheless, diverse factors must be consid-
ered in the sensitivity of XD: number of boxes used, patient
age, capacity of ingestion by the bugs [3, 12, 24, 49], strong
diuresis of triatomines with loss of initial inoculum after a
large blood meal [14, 32], complexity of the fecal metabo-
lome of triatomines that suggests that it may affect triato-
mine competence for specific T. cruzi strains [1], bacterial
microbiota in the triatomine gut [27]; influence of starva-
tion in the development of T. cruzi in Tr. infestans [31],
mortality during the incubation period and differential
regulation of parasite populations that shows that some
triatomine defense reactions discriminate not only between
molecular signals specific for trypanosome infections but
also between different strains of T. cruzi [25]. Other aspects
related with the last point also can be important in the sen-
sitivity of XD: T. cruzi genotypes amplified from single and
mixed infections [25, 32], transfer of a T. cruzi DTU from
mixture present in human blood to triatomine vector de-
pends on the specie used in the XD [41, 47], the develop-
ment of one clonal genotype from mixed infection can be
inhibited [43] and that the most important strains belong-
ing to one of the two main DTUs, developed different
population densities in the insect vector [48].
Conclusions
This study allowed the detection and quantification of T.
cruzi by qPCR-XD in FS of Tr. infestans fed on patients
with CChD. Nevertheless the different variables related
with the sensitivity of XD, the highest parasite burden
were observed in positive XD cases. qPCR-XD could be
used in different studies related with the complex T.
cruzi-vector-host interactions.
Fig. 1 Amplified products of Trypanosoma cruzi by PCR in fecal samples of human xenodiagnosis. GelRed™ stained 2 % agarose gel of amplified
products of Trypanosoma cruzi minicircle kinetoplastid PCR from fecal samples (FS) of triatomines (Triatoma infestans) fed on untreated chronic
chagasic patients (PCR-XD). Lane C: control; Lane M: 100 bp ladder; Lanes 1-10: PCR-XD positive in ten patients (band of 330 bp specific for T.
cruzi); Lane NC: FS-DNA extracted from five triatomines free infection; Lane PC: DNA T. cruzi Tulahuén strain
Table 1 Ranges of parasite burden of Trypanosoma cruzi determined by real-time PCR in samples of Triatoma infestans used in
xenodiagnosis (qPCR-XD) and peripheral blood (qPCR-B) in 100 individuals with chronic Chagas disease classified by positive or
negative XD
Positive XDa Negative XDb
n = 21 n = 79
Ranges parasite burden (parasite equivalent/ml) qPCR-XD†c qPCR-B qPCR-XD†c qPCR-B
n (%) n (%) n (%) n (%)
No Ct 0 (0) 0 (0) 13 (16.5) 17 (21.5)
0.1–1 0 (0) 8 (38.1) 27 (34.2) 29 (36.7)
1–10 2 (9.5) 7 (33.3) 32 (40.5) 30 (38.0)
10–100 5 (23.8) 4 (19.0) 5 (6.3) 2 (2.5)
100–1,000 9 (42.9) 1 (4.8) 2 (2.5) 1 (1.3)
1,000–10,000 5 (23.8) 1 (4.8) 0 (0) 0 (0)
†Heteroscedasticity detected: Levene's test, F = 187.663, P = 0.0001
aChi-square test (qPCR-XD vs qPCR-B): χ2 = 91.82, df = 5, P = 0.0001
bChi-square test (qPCR-XD vs qPCR-B): χ2 = 6.71, df = 5, P = 0.1520
cKruskal-Wallis test: χ2 = 42.48, df = 2, P = 0.0001
Abbreviation: No Ct, No threshold cycle (DNA-T.cruzi was not detected)
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Additional file
Additional file 1: Table S1. Xenodiagnosis (XD), PCR-xenodiagnosis
(PCR-XD), real-time PCR-xenodiagnosis (qPCR-XD) and real-time PCR-blood
(qPCR-B) results in 100 individuals with CChD. The ranged parasite burden
are represented by numbers 0–5: 0 (No Ct); 1 (0.1–1 par. eq./ml); 2
(1–10 par. eq./ml); 3 (10–100 par. eq./ml); 4 (100–1,000 par. eq./ml)
and 5 (1,000–10,000 par. eq./ml). (DOCX 22 kb)
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